Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19738979 | 1.00 | THRB (0.53) | THRBLMNAALDH1A1TSHRTDP1 | |
| SCHEMBL12927517 | 0.88 | THRB (0.48) | THRBLMNAALDH1A1TSHRTDP1 | |
| SCHEMBL18264885 | 0.88 | THRB (0.48) | THRBLMNAALDH1A1USP2KDM4E | |
| SCHEMBL29093054 | 0.87 | TSHR (0.47) | THRBLMNAALDH1A1TSHR | |
| SCHEMBL29093233 | 0.87 | TSHR (0.47) | THRBLMNAALDH1A1TSHR | |
| SCHEMBL619867 | 0.87 | TSHR (0.47) | THRBLMNAALDH1A1TSHR | |
| SCHEMBL428320 | 0.87 | TSHR (0.47) | THRBLMNAALDH1A1TSHR | |
| SCHEMBL3885660 | 0.87 | TSHR (0.47) | THRBLMNAALDH1A1TSHR | |
| SCHEMBL28085614 | 0.86 | THRB (0.46) | THRBLMNAALDH1A1TSHRTDP1 | |
| SCHEMBL11098678 | 0.86 | THRB (0.46) | THRBLMNAALDH1A1USP2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239947-A1 | THERMOSETTING COMPOSITION, POLYURETHANE RESIN COMPOSITION AND POLYURETHANE MOLDED BODY | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| WO-2024106457-A1 | RESIN COMPOSITION, FIBER-REINFORCED RESIN COMPOSITION AND MOLDED BODY | 出光興産株式会社 | 2024-05-23 | — | — | WO | disclosed |
| EP-4349879-A1 | CURABLE COMPOSITION, POLYURETHANE RESIN COMPOSITION, AND POLYURETHANE MOLDED BODY | Idemitsu Kosan Co.,Ltd. (JP) | 2024-04-10 | — | — | EP | disclosed |
| US-20240010798-A1 | LIGNIN COMPOSITION AND USE THEREOF | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-01-11 | — | — | US | disclosed |
| CN-117377710-A | Curable composition, polyurethane resin composition, and polyurethane molded body | 出光兴产株式会社 | 2024-01-09 | — | — | CN | disclosed |
| EP-4269504-A1 | LIGNIN COMPOSITION AND USE THEREOF | Idemitsu Kosan Co., Ltd (JP) | 2023-11-01 | — | — | EP | disclosed |
| CN-116648480-A | Lignin composition and use thereof | 出光兴产株式会社 | 2023-08-25 | — | — | CN | disclosed |
| US-11661471-B2 | Urethane-crosslinked biodegradable elastomers | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-30 | — | — | US | disclosed |
| CN-113651740-A | Monomer with acid degradation and reducibility sensitive functions and preparation method and application thereof | 温州医科大学 | 2021-11-16 | — | — | CN | disclosed |
| CN-112673062-A | Additive for cellulose ester resin and cellulose ester composition | DIC株式会社 | 2021-04-16 | — | — | CN | disclosed |
| US-20140273447-A1 | COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-09-18 | — | — | US | disclosed |
| US-20140273448-A1 | COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-09-18 | — | — | US | disclosed |
| US-20140273448-A1 | COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-09-18 | — | — | US | disclosed |
| US-20140273447-A1 | COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-09-18 | — | — | US | disclosed |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-04-17 | — | — | US | disclosed |
| EP-2700636-A1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | Asahi Kasei Chemicals Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
| WO-2013089212-A1 | SUBSTITUTED TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 塩野義製薬株式会社 (JP) | 2013-06-20 | — | — | WO | disclosed |
| EP-0035080-B1 | SHAPED BIOMEDICAL ARTICLES FORMED FROM POLYSILOXANE POLYMERS | BAUSCH & LOMB INCORPORATED (US) | 1984-08-15 | — | — | EP | disclosed |
| EP-0035080-A1 | Shaped biomedical articles formed from polysiloxane polymers | BAUSCH & LOMB INCORPORATED (US) | 1981-09-09 | — | — | EP | disclosed |
| US-4259467-A | Hydrophilic contact lens made from polysiloxanes containing hydrophilic sidechains | BAUSCH & LOMB INCORPORATED (US) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11661471-B2 | Urethane-crosslinked biodegradable elastomers | PUF60, XRCC5, XRCC6 | THRB 4150/4885LMNA 1441/4885ALDH1A1 250/4885 |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | THRB 962/4885LMNA 3658/4885ALDH1A1 405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.